Roszdravnadzor-2021-0039-V239
Type IB variation for application Roszdravnadzor-2021-0039. Type IB variation: Specification Change for Atezolimumab-R — minor update
Variation Number
Roszdravnadzor-2021-0039-V239
Type
Type IB
Application
Change
Status
Failed
Fee
€1,197
Submitted
—
Approved
—
Description
Type IB variation: Specification Change for Atezolimumab-R — minor update